2017 Seattle Patient & Survivor Conference
The Genomics of Kidney Cancer
Managing Drug Side Effects

From the Pressroom

FDA approves combination for advanced renal cell carcinoma

The approvals were based on CheckMate 214 (NCT02231749), a randomized open-label trial. Patients with previously untreat…

Continue Reading

First step to kidney cancer may occur in childhood

A single damaged cell may be all it takes to trigger aggressive and terminal kidney cancer almost a lifetime after the f…

Continue Reading

JAMA: Payments influence oncologist prescribing

Lead study author Aaron Mitchell said they also found prescriptions increased as the amount of money physicians received…

Continue Reading